Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Glaucoma

• A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
• Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension
• Phase 2, Placebo-Controlled, Study Assessing the Safety and Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Patients With Elevated Eye Pressure
• Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive
• Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
• Qlaris Phase 2 Study in NTG Patients
• Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients
• Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution
• Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
• Effect of IOP Lowering on Progressive HM
• A Phase 1/2a Study of PER-001 in Participants With Open-Angle Glaucoma
• Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma
• Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study
• Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adults in Clinical Setting
• Ocular Changes With Alpha-2 Receptor Agonist.
• Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos.
• OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects
• A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension
• Use of Methazolamide to Lower Intraocular Pressure
• Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)
• A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
• The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA
• A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension
• A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure
• Metformin as a Neuroprotective Therapy for Glaucoma - A Randomized Controlled Trial
• Nicotinamide in Glaucoma
• Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
• Morphological Changes of Ciliary Body and Trabecular Meshwork
• A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
• Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension.
• Effect of Repeated Low-Level Red-Light Therapy on Visual Field Damage in Primary Open-angle Glaucoma
• 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.
• Rocklatan® Evaluation
• Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl
• PSLT Compared to Prostaglandin Analogue Eye Drops
• Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930
• TOPICAL INSULIN FOR GLAUCOMA, Phase 1
• Topical Infliximab in Eyes With Penetrating Keratoplasty
• A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients With Progressing Open Angle Glaucoma
• A Study on the Treatment Strategy of NVG Secondary to PDR
• A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma
• A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
• Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma
• Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma
• A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101
• To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
• A Study of Yutiq Steroid Insert During Glaucoma Tube Implant Surgery
• Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension
• Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD
• Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% to LUMIGAN® In The Treatment of Chronic Open-Angle Glaucoma
• Interval Intraocular Pressure in Intravitreal Injection Study
• A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• A Study to Evaluate Safety and Tolerability of QLS-101 in NTG
• KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial
• Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).
• Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Study of LL-BMT1 in Patients With Elevated Intraocular Pressure
• Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost
• Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
• Prospective, Single Center Switching Study of 0.0015% Tafluprost Ophthalmic Solution in Primary Open-angle Glaucoma and Ocular Hypertension Patients With Corneal Disorders (Switching From 0.005% Latanoprost Ophthalmic Solution)
• Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.
• Augmented Macular Pigment-containing Nutraceutical and Central Visual Function
• From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy
• Tafluprost Preservative Free Switch Study
• Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized
• MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension
• FM101 Safety, Tolerability, Efficacy Study in the Patients With Open-Angle Glaucoma or Ocular Hypertension
• Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma
• PREFERENTIAL Study
• Effects of Topical Low Dose Preservative-free Hydrocortisone on Intraocular Pressure
• Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension
• AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
• Effect of MEMOPTIC on Visual Field of Patients Followed for a Chronic Open-angle Glaucoma
• Preservative-free Tafluprost Eye Drops in Newly Diagnosed Patients With Glaucoma
• A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
• Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance
• Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma
• CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension
• Subconjunctival Versus Direct Mitomycin C in Trabeculectomy
• Effect of Ginkgo Biloba Capsule on Visual Function of Primary Open-angle Glaucoma With Blood Stasis Syndrome
• Effect of Lowering IOP in Glaucoma Suspects With HM
• A Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension
• The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma
• Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery
• CATS Tonometer IOP Reduction Latanoprost Verses Timolol
• Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients.
• Effect of Metformin on Visual Function in Patients With Glaucoma
• Safety and IOP-Lowering Effects of WB007
• A Phase III Multinational Multicenter Investigator-Masked Randomised Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Safety of Topical Insulin Drops for Open-angle Glaucoma
• Efficacy and Safety of Latanoprost/Timolol for Primary Open Angle Glaucoma
• Open Label, Sequential-dose Study of PA5108 Latanoprost FA SR Ocular Implant for Mild-moderate Glaucoma
• Steroids and/ or Non-steroidal Anti-inflammatory Drugs in the Postoperative Regime After Trabeculectomy.
• Phosphodiesterase Inhibitors in Glaucoma Study (PhiGS)
• To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes
• The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
• Pilocarpine After Combined Cataract/Trabectome Surgery
• Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma
• Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno®
• Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®
• Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma
• Macular Pigment and Visual Performance in Glaucoma Patients
• Pilocarpine Use After Kahook Goniotomy
• Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity
• A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension
• Efficacy and Safety of XEN® Gel Stent and Post-operative Management in Patients With Open Angle Glaucoma
• Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt
• Long-term Safety and Efficacy Extension Trial of Bimatoprost SR
• Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy
• Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Once Daily and Twice Daily in Subjects With Primary Open-Angle Glaucoma SPECTRUM 6
• Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
• Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan
• A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension
• Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting
• Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.
• A Clinical Study to Evaluate the Efficacy and Safety of CKD-351
• NSAID vs Steroid in Trabeculectomy Wound Management
• DE-117 Spectrum 5 Study
• A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
• A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study
• Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• African Glaucoma Laser Trial
• Study to Learn How the Drug Aflibercept Works in in Japanese Patients With Increased Eye Pressure That is Caused by New Blood Vessels Growing in the Eye (Neovascular Glaucoma or NVG). Safety of the Drug and Patients' Tolerability of the Drug Injecti
• Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing
• Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma
• Efficacy of Tafluprost as an Adjunct to Medical Therapy for Residual Glaucoma After Trabeculectomy
• Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma Drops
• Efficacy and Safety of Lens Extraction in Patients With Pseudoexfoliation Glaucoma
• H-1337 Ophthalmic Solution Phase 1/2
• Evaluation of Safety and Efficacy of Brimonidine Tartrate Ophthalmic Suspension
• A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients
• Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension
• Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost
• Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study
• Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP
• Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension
• A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• RCT to Investigate if Prostaglandin Analogue Drops Increase the Risk of Cystoid Macular Oedema After Cataract Surgery.
• Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension
• Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)
• BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension
• Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• Efficacy and Necessity of Time Interval Between Instillation of Two Glaucoma Eye Drops
• A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study
• A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness
• PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)
• Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated With Proton Therapy for a Large Choroidal Melanoma
• Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
• Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma
• Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma
• Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily
• Safety and Efficacy Study of the Hydrus Aqueous Implant in Subjects With POAG
• A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT
• Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy
• Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG
• Triamcinolone Injections for Persistent Choroidal Effusions Post Glaucoma Surgery
• Intravitreal Ranibizumab (Lucentis®) for Neovascular Glaucoma- a Randomized Controlled Study
• Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT
• Bevacizumab Versus Mitomycin C as Trabeculectomy Adjuvant in Uncontrolled Glaucoma
• Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents
• Anterior Segment Imaging With Ultrahigh-resolution OCT in Patients With Glaucoma and PEX - a Pilot Study
• Efficacy and Safety of COMBIGAN® in Korean Patients With Primary Open Angle Glaucoma (POAG) and Normal Tension Glaucoma (NTG)
• Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration
• Study to Evaluate Safety and Efficacy of rhNGF Eye Drops Solution Versus Vehicle in Patients With Glaucoma
• Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact Lenses
• Dexmedetomidine as an Additive to Local Anaesthesia to Decrease Intraocular Pressure in Glaucoma Surgery
• Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG
• A Study Assessing the Safety and Efficacy of DE-117 in Subjects With POAG or OH Who Are Non-/Low-responders to Latanoprost: FUJI Study
• A Long-term Study of DE-117 Ophthalmic Solution Monotherapy and Concomitant Use of DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution in Patients With OAG or OH: RENGE Study
• Ahmed Glaucoma Valve Surgery With Mitomycin-C
• 24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined Therapy
• Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension
• Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma
• Primary Glaucoma Treatment Trial in Kenya and South Africa - SLT vs. Medication
• 24-hr Intraocular Pressure Control With SIMBRINZA ®
• The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery
• The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure
• Mitomycin C Trabeculectomy Trial for Glaucoma in Ethiopia
• A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma
• A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension
• Evaluation of a New Method for Instilling Eye Drops
• Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
• Blood Flow of Ophthalmic Artery and Glaucoma
• Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101
• Triamcinolone for Ahmed Glaucoma Valve
• Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma
• Intravitreal Aflibercept or Ranibizumab for Rubeosis Iridis
• "First-in-human" Study To Assess the Safety and Tolerability of PBF-677 in Healthy Volunteers
• A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
• A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO5093151 in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).
• Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension
• Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension
• Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma
• Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
• An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert
• 28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
• Pupillary Response After Glaucoma Medication
• Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both Eyes
• Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
• POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma
• Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy
• Japanese Phase 3 Study of Aflibercept in Neovascular Glaucoma Patients
• A Phase I Clinical Trial of DARC
• Stop Retinal Ganglion Cell Dysfunction Study
• The Impact of Topical Prostaglandins on the Biomechanical Properties of the Cornea in Patients With Open Angle Glaucoma
• Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method
• Ginkgo Biloba and Ocular Blood Flow in Primary Open-angle Glaucoma
• Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
• Does Oral Acetaminophen Lower Intraocular Pressure?
• Dose-Ranging Study of the Bimatoprost Ocular Insert
• Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
• Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma
• Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution
• Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension
• Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion.
• Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension
• SYL040012, Treatment for Open Angle Glaucoma
• Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension
• Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension
• Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
• A Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Surgical Intervention
• A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy or Tube Shunt
• Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)
• Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures
• A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Chronic Angle-closure Glaucoma
• An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product
• 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
• A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Comparison of Effect of Postoperative Cyclosporine A 2% Ophthalmic Emulsion and Betamethasone Eye Drop on Surgical Success of Trabeculectomy Procedure
• Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
• Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
• A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension
• Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
• A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)
• Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients
• Analysis of Aqueous and Vitreous Humor
• A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
• Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
• Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure
• Impact of Timolol/Dorzolamide Therapy on Autoregulation in Glaucoma Patients
• Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension
• A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
• Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose
• The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device
• A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma
• A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension
• Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure
• A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting
• Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
• An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More
• Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study
• Phase IIA Double-Masked Randomized Sham-Controlled Trial of QPI-1007 Delivered by a Single Intravitreal Injection to Subjects With Acute Primary Angle-Closure Glaucoma (APACG)
• A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension
• Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue
• Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®
• A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
• The Measurement of Intraocular Pressure in Normal Children Under General Anesthesia With and Without Nitrous Oxide and Anesthetic Eye Drops
• Immediate Anterior Chamber Paracentesis With A 30-Gauge Needle for Acute Primary Angle - Closure
• Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma
• A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
• Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension
• Trabeculectomy With Ologen Collagen Implant vs Trabeculectomy With Provisc in Steroid Induced Glaucoma
• Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
• Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT
• Transconjunctival Needling Revision Versus Medical Treatment
• An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
• Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
• A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension
• A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons
• Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma
• A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
• Safety Study of Aqueous Suppression After Ahmed Glaucoma Valve (AGV) Implantation
• A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
• Travoprost/Timolol vs Latanoprost/Timolol Fixed Combination Therapy
• Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Effect of Topical Glaucoma Therapy on Tear Film Stability in Healthy Subjects
• Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma
• Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments
• Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure
• Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH
• Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients
• Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma
• Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma
• BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• The Laser in Pseudoexfoliation (LIP) Study
• A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
• Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia
• Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
• Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension
• Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients
• Glaucoma Biomarkers
• Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma
• ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects
• An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
• Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients
• 24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension
• A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT
• Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
• A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP
• A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy
• A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy
• Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH)
• A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma
• Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema
• Impact of Oral Versatile Antioxidants on Glaucoma Progression
• Bimatoprost/Timolol Versus Travoprost/Timolol
• Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves
• Study of AR-13324 in Patients With Elevated Intraocular Pressure
• Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
• Efficacy and Safety of Topically Applied Medical Therapy for the Treatment of Pediatric Glaucoma
• A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension
• Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension
• Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America
• Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil
• Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
• Efficacy of Changing to TRAVATAN® From Prior Therapy
• Travacom Post Marketing Surveillance Study
• Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension
• Efficacy of Changing to TRAVATAN® From Prior Therapy
• A Study of RO5093151 in Patients With Ocular Hypertension Or Open Angle Glaucoma
• Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution
• AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure
• A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
• A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
• AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure
• Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma
• Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)
• Travoprost 3-Month Safety and Efficacy Study
• Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%
• 24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First Choice
• Efficacy and Safety Study of Combigan and 0.5% Timoptic in Normal Tension Glaucoma
• Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
• Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost
• Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery
• Switching From Preserved to Preserved-free Treatments for Glaucoma.
• A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%
• Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy
• A Study of the Safety and Efficacy of Bimatoprost Ophthalmic Solution in Paediatric Patients With Glaucoma
• Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada
• Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
• NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement
• Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye
• A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension
• Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma
• The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma
• Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma
• Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension
• Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine Therapy
• DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension
• DE-111 Against Timolol Ophthalmic Solution 0.5%
• DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5%
• Patient Preference Comparison of AZARGA Versus COSOPT
• Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
• 24-hour Efficacy of AR-12286
• Efficacy of Changing to DUOTRAV® From Prior Therapy
• Effects of Anti-Glaucoma Medications on the Ocular Surface
• Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
• Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension
• Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations
• AR-12286 in Combination With Latanoprost
• Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Divided Dose of TRAVATAN®
• Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%
• Comparison of Two Method Antimetabolites Application on Corneal Function in Trabeculectomy Surgery
• Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2%
• Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies
• Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma
• Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension
• Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome
• Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy
• Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)
• Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease
• Retinal Nerve Fibres Layers Thickness Study in Glaucomatous Patients
• Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated
• Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy of Changing to DuoTrav From Prior Therapy
• A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma
• Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
• Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy Surgery
• SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg
• Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular Hypertension
• Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension
• Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
• Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension
• Safety Study of Latanoprost Slow Release Insert
• Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma
• Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Trabeculectomy: A Study in Germany
• Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®
• A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• Use of Bevacizumab in Trabeculectomy Surgery
• Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP)
• Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
• Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients
• Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients.
• Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients
• Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data
• Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma
• A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
• The Effect of Bevacizumab on the Trabeculectomy
• Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension
• Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Effect of Alphagan on Retinal Blood Flow Autoregulation and Motion Detection in Patients With Normal Pressure Glaucoma
• Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
• Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops
• Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension
• PRM-151 in the Prevention of Scarring Following Trabeculectomy
• Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide
• Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure
• ELAZOP Switching Study in Korea
• Relationship Between Eye Pressure and Ganglion Cell Function in Eyes Receiving Latanoprost Versus Placebo
• A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG
• Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure
• Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED)
• Aqueous Mushroom Extract and Intraocular Pressure
• Safety and Efficacy of a Drug Delivery System in Glaucoma
• Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure Glaucoma
• Evaluation of Omeprazole Effect on Glaucoma
• A Comparison of the Effect of Dorzolamide and Timolol on Optic Disk Blood Flow in Patients With Open Angle Glaucoma
• Tolerance and Effect on Intraocular Pressure After Administration of SYL040012
• 24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol
• Steroids After Laser Trabeculoplasty for Glaucoma
• Argon Laser Peripheral Iridoplasty for Primary Angle Closure Glaucoma
• 24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed Combination
• A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG
• Effect of Nitrous Oxide (N2O) on Intraocular Pressure in Healthy Volunteers
• Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
• Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy
• Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination
• Steroids Versus Non-steroidal Anti-inflammatory Drugs Following Glaucoma Surgery
• Efficacy and Tolerability of Xalatan in Patients
• Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension
• Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension
• Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure
• Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination
• Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation
• Effect of Rosuvastatin on Endothelial Function in Patients With Diabetes and Glaucoma
• Evaluation of the iStent Versus Two Ocular Hypotensive Agents in Patients With Primary Open-angle Glaucoma (POAG)
• Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions
• A Study of AR-12286 in Patient With Elevated Intraocular Pressure (IOP)
• Ahmed Glaucoma Valve Alone, With Amniotic Membrane or With Mitomycin C (MMC) for Treatment of Refractory Glaucoma
• Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health
• Trabeculectomy With Mitomycin C Associated With Sub-conjunctival Injection of Ranibizumab
• A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma
• Equivalence Study of Dorzolamide 2% Eye Drops Solution
• Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension
• Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma
• Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of DuoTrav APS Versus DuoTrav
• A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients
• A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma
• Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?
• Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?
• Efficacy Study of Travoprost APS Versus TRAVATAN
• Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US
• Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension
• Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma
• COSOPT (Timolol/Dorzolamide Combination) Normal Tension Glaucoma Study (MK0507A-161)(COMPLETED)
• DuoTrav® Eye Drops As Replacement Therapy Program
• An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension
• Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG)
• Safety and Efficacy of a Glaucoma Drug Delivery System
• A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs
• Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS)
• A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma
• The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG)
• Comparing Effects of Two Fixed Combinations Ophthalmic Solutions on Ocular Blood Flow
• An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects
• Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects
• Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma
• Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative
• Non Interventional Study With Primary Open Angle Glaucoma and/or Ocular Hypertension Patients Treated With Xalacom® After Failure of Previous Antiglaucoma Therapy.
• Circadian Ocular Perfusion Pressure and Ocular Blood Flow
• A Study of Glaucoma or Ocular Hypertension in Patients Within the United States
• Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
• Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN
• How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used?
• Effects of Cosopt on IOP and on Ocular Diastolic Perfusion Pressure
• A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension
• Intraocular Pressure With Loteprednol and Dexamethasone
• Nasal Steroids in Controlled Glaucoma
• A Placebo-Controlled Study of INS117548 Ophthalmic Solution in Subjects With Glaucoma (P08650)
• Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT
• 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT
• Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension
• Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)
• Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension
• Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health
• Safety and Efficacy of Travoprost/Timolol BAC-free
• A Comparison of Azopt Versus Placebo Added to Xalatan in Patients With Elevated Intraocular Pressure (IOP) on a Prostaglandin
• Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
• Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
• 24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG
• Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma
• A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension
• A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia
• A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom
• Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects
• Lucentis for New Onset Neovascular Glaucoma
• A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma.
• Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)
• An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects
• Effects of Travatan Z and Xalatan on Ocular Surface Health
• Usefulness of Topical Non-Steroidal Anti-Inflammatory Drugs or Steroids Before Trabeculectomy and Clinical Outcomes
• Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
• A Multi-Dose Study With a Treatment for Open-Angle Glaucoma
• The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
• Effects of Non-Specific Endothelin-A Receptor Blockade on Ocular Blood Flow in Patients With Glaucoma
• Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
• Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure
• Glaucoma Adherence Study, Spain
• Glaucoma Adherence Study
• Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs
• A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Use of Ranibizumab With Mitomycin C During Trabeculectomy
• Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension
• To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension
• Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients
• Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
• A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma
• Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery
• A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.
• Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost
• Lucentis Versus Mitomycin C During Glaucoma Surgery
• Adjunctive Study of AL-37807 Ophthalmic Suspension
• Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops
• A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.
• Comparison of Latanoprost Vs. Timolol
• Patient Preference Study
• Circadian Rhythms of Aqueous Humor Dynamics in Humans
• Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.
• Prophylactic Anecortave Acetate in Patients With a Retisert Implant
• Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study
• Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty
• Intraocular Bevacizumab (Avastin) for Rubeosis Iridis
• A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)
• Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED)
• Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension
• Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery
• A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
• A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
• IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Oculusgen (Ologen) Glaucoma MMC Control in Estonia
• Ocular Hypotensive Efficacy of AR-102
• Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav
• Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension
• Adherence Assessment With Travalert Dosing Aid
• Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension
• 24-hour Intraocular Pressure (IOP) Control With the Bimatoprost/Timolol Fixed Combination
• ALPI vs Medical Therapy Effects on Optic Nerve Structure & Function
• Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty
• Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells
• Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early Glaucoma
• Ologen (OculusGen)-Glaucoma MMC Control in Pakistan
• A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension
• Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension
• Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers
• Subconjunctival Bevacizumab to Prevent Bleb Failure After Glaucoma Filtration Surgery
• Brimonidine vs ALTP in Progressing Human Glaucoma
• A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
• Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma
• MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)
• Ologen (OculusGen)-Glaucoma MMC Control Trial in India
• Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
• 24-hour Intraocular Pressure Control With Travoprost/Timolol Fixed Combination Versus Travoprost
• Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma
• Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy
• Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma
• Effects of Travoprost on Neovascular Glaucoma
• Comparison of Efficacy of Two Groups of Glaucoma Drops (Xalatan vs.Cosopt) in Reducing Eye Pressure Following Laser (SLT)Treatment in the Management of Glaucoma.
• Visual Function Changes After Intraocular Pressure Reduction
• The Role of Steroids Following Selective Laser Trabeculoplasty
• Will Restasis Eye Drops Increase Your Chance of Having a Successful Surgery?
• Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases
• Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops
• 24-hour Study of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations
• Intravitreal Bevacizumab for Neovascular Glaucoma
• A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).
• IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy
• 12-Month Stability of Diurnal IOP Control on Cosopt
• A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension
• Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension
• Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
• A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension
• Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
• Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost
• Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
• INFLUENCE OF TOPICAL INDOMETHACIN ON HYPOTHENSIVE EFFECT OF BRIMONIDINE
• Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin C
• A Comparison of Three Different Formulations of Prednisolone Acetate 1%
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• 24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients
• An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance
• A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• Anecortave Acetate in Patients With Open-angle Glaucoma
• Study of Medical Treatment of Low-Pressure (Normal Tension) Glaucoma
• A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients
• Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
• Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device
• A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma
• Effects of Common Topical Glaucoma Therapy on Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure and Artificially Elevated Intraocular Pressure in Healthy Humans
• Assessing Cosopt Switch Patients
• The Canadian Glaucoma Study
• Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery
• Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure
• Effect of Age on Latanoprost 0.005% in Patients With Glaucoma
• Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension
• Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension
• Memantine in Patients With Chronic Glaucoma
• A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma
• Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide
• A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension
• Corneal Versus Conjunctival Delivery Using a Delivery Device
• Memantine in Patients With Chronic Glaucoma
• Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension.
• A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma
• Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan
• Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)
• Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
• Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients
• Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension
• A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension
• Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension
• Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension
• A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension
• A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
• A Long-term Safety Study of Once-daily Travatan
• A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)
• A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
• Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32
• Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98
• Study of TRAVATAN in Subjects With Iris Pigmentation Changes
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41
• Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69
• Collaborative Initial Glaucoma Treatment Study (CIGTS)
• Early Manifest Glaucoma Trial (EMGT)
• Ocular Hypertension Treatment Study (OHTS)
• Fluorouracil Filtering Surgery Study (FFSS)